Katarina Sjögreen Gleisner
41 – 50 of 85
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Variations in the practice of molecular radiotherapy and implementation of dosimetry : results from a European survey
(
- Contribution to journal › Article
-
Mark
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
(
- Contribution to journal › Article
-
Mark
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy : The Devil Is in the Details
(
- Contribution to journal › Article
- 2016
-
Mark
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.
(
- Contribution to journal › Article
-
Mark
Biologically effective dose in fractionated molecular radiotherapy-application to treatment of neuroblastoma with (131)I-mIBG.
(
- Contribution to journal › Article
-
Mark
Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer
(
- Contribution to journal › Article
-
Mark
Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.
(
- Contribution to journal › Article
-
Mark
Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
(
- Contribution to journal › Scientific review
-
Mark
Uncertainty propagation for SPECT/CT-based renal dosimetry in (177)Lu peptide receptor radionuclide therapy.
(
- Contribution to journal › Article